U.S. flag

An official website of the United States government

NM_000426.4(LAMA2):c.1854_1861dup (p.Leu621fs) AND Inborn genetic diseases

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 5, 2016
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000624032.2

Allele description [Variation Report for NM_000426.4(LAMA2):c.1854_1861dup (p.Leu621fs)]

NM_000426.4(LAMA2):c.1854_1861dup (p.Leu621fs)

Gene:
LAMA2:laminin subunit alpha 2 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
6q22.33
Genomic location:
Preferred name:
NM_000426.4(LAMA2):c.1854_1861dup (p.Leu621fs)
HGVS:
  • NC_000006.12:g.129250183_129250190dup
  • NG_008678.1:g.372043_372050dup
  • NM_000426.4:c.1854_1861dupMANE SELECT
  • NM_001079823.2:c.1854_1861dup
  • NP_000417.3:p.Leu621fs
  • NP_001073291.2:p.Leu621fs
  • LRG_409:g.372043_372050dup
  • NC_000006.11:g.129571327_129571328insACGTGTTC
  • NC_000006.11:g.129571328_129571335dup
  • NM_000426.3:c.1854_1861dupACGTGTTC
  • NM_000426.4:c.1854_1861dup
Protein change:
L621fs
Links:
dbSNP: rs202247791
NCBI 1000 Genomes Browser:
rs202247791
Molecular consequence:
  • NM_000426.4:c.1854_1861dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001079823.2:c.1854_1861dup - frameshift variant - [Sequence Ontology: SO:0001589]
Observations:
1

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000741359Ambry Genetics
criteria provided, single submitter

(Ambry exome assertion method (8-5-2015))
Pathogenic
(Feb 5, 2016)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
African American/Caucasian/Hispanic/Native Americangermlineyes1not providednot provided1not providedclinical testing

Details of each submission

From Ambry Genetics, SCV000741359.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1African American/Caucasian/Hispanic/Native American1not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided

Last Updated: Sep 29, 2024